Fate Therapeutics (FATE) Net Cash Flow (2012 - 2026)
Fate Therapeutics (FATE) posted Net Cash Flow of -$7.2 million for Q1 2026, down 220.46% on a QoQ basis from $6.0 million in Q4 2025, and down 181.62% year-over-year from $8.9 million in Q1 2025.
Fate Therapeutics (FATE) Net Cash Flow (2012 - 2026) Analysis & Trends
Fate Therapeutics' Net Cash Flow history runs 15 years deep, the most recent figure standing at -$7.2 million for Q1 2026.
- Quarterly Net Cash Flow fell 181.62% year-over-year to -$7.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$5.5 million (up 93.21% YoY) and the FY2025 annual result came in at $10.6 million, up 198.22% from the prior year.
- Net Cash Flow was -$7.2 million for Q1 2026 at Fate Therapeutics, down from $6.0 million in the prior quarter.
- Across five years, Net Cash Flow topped out at $79.5 million in Q1 2024 and bottomed at -$84.4 million in Q2 2024.
- A 5-year average of -$5.8 million and a median of -$3.7 million in 2025 frame the typical range for Net Cash Flow.
- Peak annual rise in Net Cash Flow reached 511.39% in 2024, while the deepest fall reached 1883.71% in 2024.
- Fate Therapeutics' Net Cash Flow stood at -$20.8 million in 2022, then soared by 141.12% to $8.5 million in 2023, then slumped by 121.71% to -$1.9 million in 2024, then soared by 424.12% to $6.0 million in 2025, then plunged by 220.46% to -$7.2 million in 2026.
- Business Quant data shows FATE's Net Cash Flow at -$7.2 million in Q1 2026, $6.0 million in Q4 2025, and -$627000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 10.56 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 224.46 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.34 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 457.40 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -152.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 57.19 Mn |
| 10 | Fate Therapeutics | 302.48 Mn | 302.48 Mn | - | -7.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7.24 Mn |
| Mar 31, 2026 | -7.24 Mn |
| Dec 31, 2025 | 6.01 Mn |
| Dec 31, 2025 | 6.01 Mn |
| Sep 30, 2025 | -627,000.00 |
| Sep 30, 2025 | -627,000.00 |
| Jun 30, 2025 | -3.67 Mn |
| Jun 30, 2025 | -3.67 Mn |
| Mar 31, 2025 | 8.86 Mn |
| Mar 31, 2025 | 8.86 Mn |
| Dec 31, 2024 | -1.85 Mn |
| Dec 31, 2024 | -1.85 Mn |
| Sep 30, 2024 | -3.96 Mn |
| Sep 30, 2024 | -3.96 Mn |
| Jun 30, 2024 | -84.41 Mn |
| Jun 30, 2024 | -84.41 Mn |
| Mar 31, 2024 | 79.45 Mn |
| Mar 31, 2024 | 79.45 Mn |
| Dec 31, 2023 | 8.54 Mn |
| Dec 31, 2023 | 8.54 Mn |